Radioligand Therapy Market Size, Share, Growth & Industry Analysis, By Product Type (Approved Products, Pipeline Products), By Biomarker (Prostate-Specific Membrane Antigen, Cytochrome P450 17A1 Inhibitor, Ki-67 Expression and Grading), By End User (Hospitals, Clinics, Academic & Research Institutes, Others) and Regional Analysis, 2024-2031
Pages: 120 | Base Year: 2023 | Release: April 2024 | Author: Saket A.
Buy Now